Primary Site >> Biliary tract Cancer
Gene >> ZEB1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. PMID: 19116147 Ref: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. PMID: 20309424 |
Ref: Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. PMID: 24135722 Ref: EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. PMID: 24704591 Ref: Forkhead box L1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction. PMID: 25010679 |
Ref: FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. PMID: 25749036 Ref: Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in GBC-SD/M and GBC-SD gallbladder cancer cell lines. PMID: 25893892 Ref: Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. PMID: 26043778 |
Ref: ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma. PMID: 26670746 Ref: A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer. PMID: 26726879 Ref: Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. PMID: 27655691 |
Ref: Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer. PMID: 28677740 |
Ref: Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 29732001 Ref: Serum nardilysin, a surrogate marker for epithelial-mesenchymal transition, predicts prognosis of intrahepatic cholangiocarcinoma after surgical resection. PMID: 30352908 |